Trials / Completed
CompletedNCT00627731
Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients
Phase 4, Randomized Study of Oral Glucocorticosteroid Administration in the Treatment of Acute Severe Asthma Exacerbation in Hospitalized Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Hamamatsu University · Academic / Other
- Sex
- All
- Age
- 16 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A comparison of oral prednisolone administration with intravenous methylprednisolone infusion in the treatment of acute asthma exacerbation in hospitalized patients. Oral glucocorticosteroids administration may be effective as intravenous high-dose methylprednisolone infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | methylprednisolone sodium succinate (mPSL) | mPSL IV 240mg per day for 5 days and oral PSL 40mg per day for 5 days |
| DRUG | prednisolone (PSL) | PSL 40 mg per day for 10 days |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2008-03-03
- Last updated
- 2011-09-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00627731. Inclusion in this directory is not an endorsement.